Infectious Disease Expertise
SGS has 40 years of experience bringing infectious disease compounds through the complete clinical development cycle. As a global CRO, SGS provides integrated solutions from pre-clinical activities including formulation development, to clinical development consultancy and full service Phase I-IV clinical trials including clinical manufacturing and analytical laboratory services as well as bioanalysis, biosafety testing and immunoassays.
Integrated Services In the last five years, SGS has completed more than 182 infectious disease clinical projects, spanning the full spectrum of SGS services from Phase I through Phase IV, including scientific consulting for drug development programs, regulatory guidance, clinical site recruitment and management, clinical trial monitoring and management, biometrics, medical monitoring, and pharmacovigilance. In addition to its hospital embedded Clinical Pharmacology Units in Belgium and Hungary, SGS has developed relationships with a wide network of leading infectious disease experts in the field by means of participation in clinical studies as well as collaboration on scientific advisory boards,
specialist consortia, and safety review committees. The entire SGS team is experienced and aligned to current infectious disease challenges with the ability to rapidly initiate, monitor and manage
complex drug and vaccines trials. Site Selection & Feasibility
SGS maintains a proprietary database of potential investigator sites with active recruitment and ongoing feasibility studies in infectious disease indications. With this large investigator database, SGS can provide accurate recruitment potential and inclusion/exclusion feedback on a protocol within 2-4 weeks.
Made with FlippingBook - Share PDF online